Source:http://linkedlifedata.com/resource/pubmed/id/16096320
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2005-9-28
|
pubmed:abstractText |
To determine the global distribution of TEM-1 and ROB-1 beta-lactamases in Haemophilus influenzae isolated from patients with community-acquired respiratory tract infection during the first 4 years of the PROTEKT study (1999-2003). To investigate the activities of commonly used antibiotics against these isolates.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0305-7453
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
773-6
|
pubmed:dateRevised |
2008-8-22
|
pubmed:meshHeading |
pubmed-meshheading:16096320-Haemophilus influenzae,
pubmed-meshheading:16096320-Helicobacter Infections,
pubmed-meshheading:16096320-Humans,
pubmed-meshheading:16096320-Microbial Sensitivity Tests,
pubmed-meshheading:16096320-Respiratory Tract Infections,
pubmed-meshheading:16096320-World Health,
pubmed-meshheading:16096320-beta-Lactamases
|
pubmed:year |
2005
|
pubmed:articleTitle |
Global distribution of TEM-1 and ROB-1 beta-lactamases in Haemophilus influenzae.
|
pubmed:affiliation |
GR Micro Limited, 7-9 William Road, London NW1 3ER, UK. D.Farrell@grmicro.co.uk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|